nabiximols

GW Pharma Hopes to Bring Its Second Cannabis-Based Drug to Market in the U.S.
BioSpace
Tue, 11/3/20 - 09:34 pm
GW Pharma
cannabindoids
multiple sclerosis
spasticity
nabiximols
Sativex